Biological Findings and Clinical Outcomes in Patients Treated With R‐CHOP Plus High‐Dose Methotrexate as First‐Line Therapy in Large B‐Cell Lymphoma With Testis Involvement
Authors:
Open Access
- 12 October 2024
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 114 (1) , 186-194
Abstract
Primary testicular lymphoma (PTL) is a rare occurrence of diffuse large B‐cell lymphoma (DLBCL) that accounts for 1%–2% of all cases. Nodal DLBCL with testis involvement (DLBCL‐T) and PTL are associated with poor prognosis, with high incidence of central nervous system relapse. Fifteen patients (median age 60 years) with PTL (n = 5) or DLBCL‐T (n = 10) received high‐dose methotrexate + R‐CHOP. Overall, complete response (CR) rate was 73% and overall response rate 86%. With a 3.9‐year median follow‐up, 100% of patients with PTL had CR and none relapsed. On the contrary, 55% of DLBCL‐T patients achieved CR among which only one was still in remission at the end of follow‐up. Molecular parallels between PTL and Primary CNS Lymphoma (PCNSL) suggest shared origins, urging further research for tailored treatments and enhanced understanding of these lymphomas' biology.Keywords
This publication has 41 references indexed in Scilit:
- CNS prophylaxis for diffuse large B-cell lymphomaThe Lancet Oncology, 2022
- Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Genetics in Medicine, 2022
- Interpretation of retrospective data evaluating high‐dose methotrexate as central nervous system prophylaxis in diffuse large B‐cell lymphoma; caution requiredAmerican Journal of Hematology, 2021
- Ineffectiveness of high‐dose methotrexate for prevention of CNS relapse in diffuse large B‐cell lymphomaAmerican Journal of Hematology, 2021
- Intravenous but not intrathecal central nervous system–directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphomaEuropean Journal of Cancer, 2019
- Antigen selection in B-cell lymphomas—Tracing the evidenceSeminars in Cancer Biology, 2013
- Phenotype profiling of primary testicular diffuse large B‐cell lymphomasHematological Oncology, 2013
- Molecular Characterization of Immunoglobulin Gene Rearrangements in Diffuse Large B-Cell LymphomaThe American Journal of Pathology, 2012
- Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphomaCancer, 2010
- Testicular lymphoma is associated with a high incidence of extranodal recurrenceCancer, 2000